Fig. 4
From: Repurposed agents in the Alzheimer’s disease drug development pipeline

Repurposing trials over time in the Alzheimer’s disease drug development pipeline (2016–2020)
From: Repurposed agents in the Alzheimer’s disease drug development pipeline
Repurposing trials over time in the Alzheimer’s disease drug development pipeline (2016–2020)